+3 | The top 3 med-tech stories for May 10, 2012.

May 10, 2012 by MassDevice staff

Riata's survival rates called "significantly worse" in an independent study, DePuy may be showing its hand in defending its recalled metal-on-metal hips ahead of court hearings and Covidien denies a widely disseminated rumor that it cut 200 workers to offset the cost of the medical device tax.

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.